Literature DB >> 6873616

Intrahepatic cholestasis and sicca complex after thiabendazole. Report of a case and review of the literature.

D Rex, L Lumeng, J Eble, L Rex.   

Abstract

Thiabendazole is a relatively safe and effective agent with a wide range of activity against nematodes infesting the gastrointestinal tract. A 55-yr-old man developed prolonged jaundice and sicca complex after a course of thiabendazole therapy. Endoscopic retrograde cholangiopancreatography demonstrated normal biliary tree and pancreatic ducts. Liver biopsy was consistent with a drug-induced intrahepatic cholestatic reaction. The patient recovered completely from his liver injury, but the sicca complex persisted 1 yr after the drug was given. The literature on thiabendazole-induced cholestasis and its association with sicca complex is reviewed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6873616

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Thiabendazole inhibits ubiquinone reduction activity of mitochondrial respiratory complex II via a water molecule mediated binding feature.

Authors:  Qiangjun Zhou; Yujia Zhai; Jizhong Lou; Man Liu; Xiaoyun Pang; Fei Sun
Journal:  Protein Cell       Date:  2011-08-06       Impact factor: 14.870

Review 2.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

3.  Micronodular cirrhosis after thiabendazole.

Authors:  M A Roy; F W Nugent; H T Aretz
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.